Consolidated Statements of Expenses (Unaudited) (USD $)	3 Months Ended
	May 31, 2014	May 31, 2013
Revenue
Revenue
Total revenue
OPERATING EXPENSES
General & administrative	535,501	1,300,641
Research & development	253,082	99,715
Total Operating Expenses	788,583	1,400,356
Operating Loss	(788,583)	(1,400,356)
OTHER (INCOME) EXPENSE
Interest income	58,673	28,800
Accretion expense	342,073	173,982
Deferred financing costs amortization	45,392
Miscellaneous income	(2,637)
Interest income		(61)
Total Other Expense	443,501	202,721
NET LOSS	$ (1,232,084)	$ (1,603,077)
Net loss per share, basic and diluted	$ (0.06)	$ (0.08)
Weighted average of shares outstanding	21,622,812	21,300,995